CN101129875A - 一种治疗传染性软疣的中药组合物 - Google Patents
一种治疗传染性软疣的中药组合物 Download PDFInfo
- Publication number
- CN101129875A CN101129875A CNA2007101209550A CN200710120955A CN101129875A CN 101129875 A CN101129875 A CN 101129875A CN A2007101209550 A CNA2007101209550 A CN A2007101209550A CN 200710120955 A CN200710120955 A CN 200710120955A CN 101129875 A CN101129875 A CN 101129875A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- medicine composition
- molluscum contagiosum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 239000000203 mixture Substances 0.000 title claims abstract description 9
- 208000008588 molluscum contagiosum Diseases 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 18
- 239000010231 banlangen Substances 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 19
- 208000015181 infectious disease Diseases 0.000 abstract description 4
- 208000000260 Warts Diseases 0.000 abstract description 2
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000002458 infectious effect Effects 0.000 abstract description 2
- 201000010153 skin papilloma Diseases 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 230000008961 swelling Effects 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000005647 Mumps Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 206010022000 influenza Diseases 0.000 description 3
- 208000010805 mumps infectious disease Diseases 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010052369 Encephalitis lethargica Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 208000003443 Unconsciousness Diseases 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 201000002498 viral encephalitis Diseases 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033425 Pain in extremity Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 241000934136 Verruca Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000036566 epidermal hyperplasia Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000008127 lead poisoning Diseases 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗传染性软疣的中药组合物,它是以大青叶、金银花、菊花和黄芩等10多味中草药为原料。具有清热解毒,理气凉血的功效。本发明是在传统的中医辨证治疗的基础上结合现代最新科研成果研制而成的。本发明的目的是提供一种治疗传染性软疣的中药组合物。具有疗效确切、安全方便、无毒副作用、价格低廉的特点。
Description
技术领域
本发明涉及一种治疗传染性软疣的中药组合物,是一种治疗传染性软疣以中草药为原料的中药组合物。属于中药领域。
背景技术
传染性软疣是由传染性软疣病毒引起的良性表皮增生性传染性皮肤病。男女发病无差异,可见于任何年龄,但好发于儿童及青年人。四季均可发病,夏秋季节多见。本病属于中医学“鼠乳”范畴,俗称“水瘊子”。本病多由外感风热毒邪,客于肌肤,博结腠理致气血失和而发;或由脾虚中焦失运,后天生化之源不足,肌肤失养,腠理不密,复感外邪,邪毒聚结肌肤而生。《诸病源候论·鼠乳候》记载“鼠乳者,身面忽而生肉,如鼠乳之状,谓之鼠乳也。此亦是风邪博于肌肉而变生也”。中医药治疗本病内外兼治。外治者治其标,内治者治其本。对皮损播散,反复发作者宜扶正祛邪,以调整和增强机体自身抗病能力为要。中医在临床上分风热客表证、脾虚湿困证等症型辨证治疗,取得很好效果。发明一种既安全又有效的中药制剂,具有重大意义。
发明内容
本发明是在传统的中医辨证治疗的基础上结合现代最新科研成果研制而成的。本发明的目的是提供一种治疗传染性软疣的中药组合物。具有疗效确切、安全方便、无毒副作用、价格低廉的特点。
本发明是由下述重量配比的原料药制成的:
金银花1.5~6份 生地黄1.0~4份 菊花0.1~2份
板蓝根1.5~6份 紫草0.1~2份 木贼0.1~2份
大青叶1.5~6份 柴胡0.1~2份 黄芩0.1~2份
生薏苡仁1.0~4份 生甘草0.1~2份。
本发明的优选配方各原料药的重量配比是:
金银花2.5~3.5份 生地黄1.5~2.5份 菊花0.5~1.5份
板蓝根2.5~3.5份 紫草0.5~1.5份 木贼0.5~1.5份
大青叶2.5~3.5份 柴胡0.5~1.5份 黄芩0.5~1.5份
生薏苡仁1.5~2.5份 生甘草0.5~1.5份。
本发明的最佳配方各原料药的重量配比是:
金银花3份 生地黄2份 菊花1份
板蓝根3份 紫草1份 木贼1份
大青叶3份 柴胡1份 黄芩1份
生薏苡仁2份 生甘草1份。
本发明中的药物机理如下:
金银花药性甘,寒。归肺、胃经。具有清热解毒的功效。可治疗外感风热或温病发热,中暑,热毒血痢,痈肿疔疮,喉痹,多种感染性疾病等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第1972页)。
板蓝根药性苦,寒。归心、肺、肝、胃经。具有清热,解毒,凉血,利咽的功效。可治疗风热感冒,流感,流脑,乙脑,大头瘟疫,烂喉丹痧,丹毒,痄腮,咽喉肿痛,黄疸,水痘,麻疹等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第1806页)。
大青叶性味苦、寒。归肝、心、胃经。具有清热解毒,凉血消斑的功效。可治疗温病热盛烦渴,发斑发疹,高热神昏,流行性感冒,急性传染性肝炎,菌痢,急性胃肠炎,急性肺炎,丹毒,吐血衄血,黄疸,咽喉肿痛,喉痹,痄腮,口疮,痈疽肿毒,流行性腮腺炎,流行性脑脊髓膜炎,流行性乙型脑炎,上呼吸道感染,钩虫,皮炎,无名热,钩端螺旋体,解铅毒等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第129页)。
生薏苡仁药性甘、淡,微寒。归脾、胃、肺经。具有利湿健脾,舒筋除痹,清热排脓的功效。可治疗水肿,脚气,小便淋沥,湿温病,泄泻,带下,风湿痹痛,筋脉拘挛,肺痈,肠痈,扁平疣等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第3725页)。
生地黄性味甘、寒。归心、肝、肾经。具有清热凉血,养阴,生津的功效。可治疗热病舌绛烦渴、阴虚内热、骨蒸劳热、内热消渴、吐血、衄血、发斑发疹等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第514页)。
紫草药性苦、寒。归心、肝经。具有凉血活血,解毒透疹的功效。可治疗吐血,衄血,尿血,紫癜,斑疹,麻疹,黄疸,痈疽,烫伤等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第3272页)。
柴胡性味苦、微寒。归肝、胆经。具有和解表里、疏肝、升阳的功效。可治疗寒热往来、胸满胁痛、耳聋、头痛目眩、疟疾、下痢脱肛、月经不调、子宫下垂、感冒、上呼吸道感染、肝炎、胆囊炎等。(季宇彬主编《抗癌中药药理与应用》黑龙江科学技术出版社1999年版第1004页)。
生甘草药性甘,平。归脾、胃、心、肺经。具有和中缓急,润肺,解毒,调和诸药的功效。可治疗脾胃虚弱,倦怠食少,腹痛便溏,四肢挛急疼痛,心悸,脏躁,肺痿咳嗽;生用治咽喉肿痛,痈疮肿毒,小儿胎毒,及药物、食物中毒等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第792页)。
菊花药性甘、苦,微寒。归肺、肝经。具有疏风清热,平肝明目,解毒消肿的功效。可治疗外感风热或风温初起,发热头痛,眩晕,目赤肿痛,疔疮肿毒等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第2900页)。
木贼药性甘、微苦,平。归肺、肝、胆经。具有疏风散热,明目退翳,止血的功效。可治疗风热目赤,目生云翳,迎风流泪,肠风下血,痔血,血痢,妇人月水不断,脱肛等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第482页)。
黄芩药性苦,寒。归肺、心、肝、胆、大肠经。具有清热泻火,燥湿解毒,止血,安胎的功效。可治疗肺热咳嗽,热病高热神昏,肝火头痛,目赤肿痛,湿热黄疸,泻痢,热淋,吐衄,崩漏,胎热不安,痈肿疗疮等。(《中药大辞典》南京中医药大学编著上海科学技术出版社第二版第2808页)。
本发明遵循中医“君臣佐使”的组方原则,用金银花、板蓝根和大青叶为君药;用生薏苡仁、生地黄、紫草、菊花、黄芩和木贼为臣药;用柴胡和生甘草为佐使药。诸药相合,共具清热解毒,理气凉血的功效。治疗传染性软疣具有疗效确切,无毒副作用,服用方便,价格低廉的特点。
本发明药物临床使用结果表明,有如下优点:
1、本发明选用的中草药各组份符合中华人民共和国药品管理法的规定,利用各味中药的综合作用治疗传染性软疣,对人体无毒无害。经动物急、慢性毒性实验表明被实验的动物未见任何毒性反应,其主要脏器也无明显的改变,药物安全可靠。
2、本发明药中富含蛋白质,葡萄糖,葡萄糖醛酸,挥发油,果胶,果糖,有机酸,卵磷脂,维生素,氨基酸,还含皂甙,植物甾醇和钙等多种微量元素,利于人体吸收,增强体质。
3、本发明不仅可有效的治疗传染性软疣,对传染性软疣的预防也有很好的作用,治疗传染性软疣具有疗效确切,无毒副作用,服用方便,价格低廉的特点。
为表明本发明药物对治疗传染性软疣的治疗效果,经临床试验结果如下;治疗传染性软疣患者18例。服用实施例汤剂,每次1袋,一日二至三次,饭前半小时服用。一个月为一个疗程,连续服用三个疗程观察疗效。治愈14例占77.78%,好转3例占16.67%,未愈1例占5.56%,总有效率达94.45%。经三个疗程治疗后,病人无任何不良反应,三大常规化验及肝肾功能检测未发现异常。
具体实施方式
实施例 汤剂 按下述重量称取原料药:
金银花3份 生地黄2份 菊花1份
板蓝根3份 紫草1份 木贼1份
大青叶3份 柴胡1份 黄芩1份
生薏苡仁2份 生甘草1份。
制备方法是取上述原料洗净去杂,晾干,粉碎成颗粒,加水浸泡1小时,置多功能提取罐中加水煎煮二次,第一次加总药材10倍量的水,煎煮1.5~2小时,取煎液,滤过。第二次加总药材7倍量的水,煎煮1~1.2小时,取两次煎液,滤过,热封袋中,105℃高温灭菌,包装即得。本发明制成的治疗传染性软疣的汤剂为塑封袋装,每袋210ml,口服,一次一袋,每日二至三次。一个月为一个疗程。
Claims (3)
1.一种治疗传染性软疣的中药组合物,其特征在于它是由下述重量配比的原料药制成的:
金银花 1.5~6份 生地黄 1.0~4份 菊花 0.1~2份
板蓝根 1.5~6份 紫 草 0.1~2份 木贼 0.1~2份
大青叶 1.5~6份 柴 胡 0.1~2份 黄芩 0.1~2份
生薏苡仁1.0~4份 生甘草 0.1~2份。
2.根据权利要求1所述的一种治疗传染性软疣的中药组合物,其中各原料药的重量配比是:
金银花 2.5~3.5份 生地黄 1.5~2.5份 菊花 0.5~1.5份
板蓝根 2.5~3.5份 紫 草 0.5~1.5份 木贼 0.5~1.5份
大青叶 2.5~3.5份 柴 胡 0.5~1.5份 黄芩 0.5~1.5份
生薏苡仁1.5~2.5份 生甘草 0.5~1.5份。
3.根据权利要求1所述的一种治疗传染性软疣的中药组合物,其中各原料药的重量配比是:
金银花 3份 生地黄 2份 菊花 1份
板蓝根 3份 紫 草 1份 木贼 1份
大青叶 3份 柴 胡 1份 黄芩 1份
生薏苡仁2份 生甘草 1份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101209550A CN101129875A (zh) | 2007-08-29 | 2007-08-29 | 一种治疗传染性软疣的中药组合物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007101209550A CN101129875A (zh) | 2007-08-29 | 2007-08-29 | 一种治疗传染性软疣的中药组合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101129875A true CN101129875A (zh) | 2008-02-27 |
Family
ID=39127387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007101209550A Pending CN101129875A (zh) | 2007-08-29 | 2007-08-29 | 一种治疗传染性软疣的中药组合物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101129875A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920958A (zh) * | 2012-10-23 | 2013-02-13 | 陈向荣 | 一种治疗传染性软疣的中药组合物 |
| CN104383481A (zh) * | 2014-11-03 | 2015-03-04 | 山东瑞康生命科技有限公司 | 一种治疗鼠乳的中药制剂及其制备方法 |
-
2007
- 2007-08-29 CN CNA2007101209550A patent/CN101129875A/zh active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102920958A (zh) * | 2012-10-23 | 2013-02-13 | 陈向荣 | 一种治疗传染性软疣的中药组合物 |
| CN104383481A (zh) * | 2014-11-03 | 2015-03-04 | 山东瑞康生命科技有限公司 | 一种治疗鼠乳的中药制剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100571731C (zh) | 一种治疗带状疱疹的中药汤剂 | |
| CN101112518A (zh) | 一种治疗产后血虚发热的中药制剂 | |
| CN101095780A (zh) | 治疗糖尿病性脂肪肝的中药制剂 | |
| CN101095907A (zh) | 一种治疗糖尿病性末梢神经炎的中成药 | |
| CN101116714A (zh) | 一种治疗传染性软疣的中药制剂 | |
| CN101066338A (zh) | 一种治疗经行风疹块的中药 | |
| CN101066320A (zh) | 一种治疗经行风疹块的中药组合 | |
| CN101249151A (zh) | 一种治疗风湿痹的中药制剂 | |
| CN101053650A (zh) | 一种治疗脂溢性脱发的中药制剂 | |
| CN101085281A (zh) | 治疗慢性肾炎的一种中药 | |
| CN101085313A (zh) | 一种治疗倒经的中药制剂 | |
| CN101085259A (zh) | 治疗慢性肾炎的中药汤剂 | |
| CN101130034A (zh) | 治疗乳腺增生症的一种中药组合物 | |
| CN101085212A (zh) | 一种治疗慢性肾炎的中药 | |
| CN101095776A (zh) | 一种治疗糖尿病性耳聋的中成药 | |
| CN101066381A (zh) | 一种治疗经间期出血的中药制剂 | |
| CN101129644A (zh) | 一种治疗乳房湿疹的中药制剂 | |
| CN104606395A (zh) | 一种治疗经行发热的中药方剂 | |
| CN101085312A (zh) | 一种治疗甲亢的中药 | |
| CN101085179A (zh) | 治疗尿毒症的中药制剂 | |
| CN101574474A (zh) | 一种治疗紫癜的中药组合物 | |
| CN101129505A (zh) | 一种治疗颈椎病的中药制剂 | |
| CN101129750A (zh) | 一种治疗少儿乳房异常发育症的中药组合物 | |
| CN101129993A (zh) | 一种治疗乳腺增生症的中药组合物 | |
| CN101095922A (zh) | 一种治疗糖尿病性末梢神经炎的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20080227 |